Malignant neoplasm of stomach
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We recently reported the isolation of the K-sam complementary DNA (cDNA), which was amplified preferentially in poorly differentiated types of stomach cancer and codes for one of the heparin-binding growth factor or fibroblast growth factor (FGF) receptor families.
|
1317750 |
1992 |
Stomach Carcinoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We recently reported the isolation of the K-sam complementary DNA (cDNA), which was amplified preferentially in poorly differentiated types of stomach cancer and codes for one of the heparin-binding growth factor or fibroblast growth factor (FGF) receptor families.
|
1317750 |
1992 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
Previously we reported the purification of the heparin-binding growth factor pleiotrophin (PTN) from supernatants of the human breast cancer cell line MDA-MB-231.
|
1464602 |
1992 |
Breast Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Previously we reported the purification of the heparin-binding growth factor pleiotrophin (PTN) from supernatants of the human breast cancer cell line MDA-MB-231.
|
1464602 |
1992 |
Rheumatoid Arthritis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Since heparin binding growth factor (HBGF)-1, the precursor of acidic fibroblast growth factor (FGF), is a potent angiogenic polypeptide and mitogen for mesenchymal cells, we sought evidence that it was involved in the synovial pathology of RA and SCW arthritis.
|
1691192 |
1990 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.
|
7533562 |
1994 |
Breast Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.
|
7533562 |
1994 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
|
7678839 |
1993 |
Esophageal Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer.
|
11479204 |
2001 |
Esophageal carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer.
|
11479204 |
2001 |
Malignant neoplasm of esophagus
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer.
|
11479204 |
2001 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Midkine (MK), a heparin binding growth factor, and cyclooxygenase-2 (COX-2), a key enzyme in the conversion of arachidonic acid to prostaglandin, are both up-regulated at the mRNA or protein level in many human malignant tumors.
|
11781662 |
2001 |
Neoplasm Metastasis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Heparin affin regulatory peptide (HARP) is an heparin-binding growth factor, highly expressed in several primary human tumors and considered as a rate-limiting angiogenic factor in tumor growth, invasion, and metastasis.
|
12070152 |
2002 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Heparin affin regulatory peptide (HARP) is an heparin-binding growth factor, highly expressed in several primary human tumors and considered as a rate-limiting angiogenic factor in tumor growth, invasion, and metastasis.
|
12070152 |
2002 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.
|
12686563 |
2003 |
Primary malignant neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.
|
12686563 |
2003 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The heparin-binding growth factor midkine (MK) is the product of a retinoic acid-responsive gene, and is implicated in neuronal survival and differentiation, and carcinogenesis.
|
12771916 |
2003 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Elevated nuclear HDGF levels were found to be correlated with loss of differentiation features (P < 0.05), absence of tumor capsules (P < 0.01), high alpha-fetoprotein levels (P < 0.05), and overexpression of proliferating cell nuclear antigen (P < 0.001).
|
14508832 |
2003 |
Liver carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
HDGF levels in hepatoma tissue samples were significantly higher than in adjacent nontumor tissue samples (P < 0.05).
|
14508832 |
2003 |
Liver neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
HDGF levels in hepatoma tissue samples were significantly higher than in adjacent nontumor tissue samples (P < 0.05).
|
14508832 |
2003 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
However, these stable transfectants overexpressing HDGF generated sarcomatous tumors in nude mice.
|
14662017 |
2003 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
In the present study, we investigated the role of HDGF in tumorigenesis and elucidated the mechanism of action.
|
14662017 |
2003 |
Rheumatoid Arthritis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis.
|
15146411 |
2004 |
HIV Infections
|
0.300 |
Biomarker
|
group |
CTD_human |
Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
|
15308739 |
2004 |
HIV Coinfection
|
0.300 |
Biomarker
|
disease |
CTD_human |
Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
|
15308739 |
2004 |